Chemo Response Foretold by Leukemia Stem Cell Biomarker
Felicia Rodriguez
December 8, 2016
Princess Margaret Cancer Centre in Toronto is utilizing LSC17, a biomarker found in Leukemia Stem Cells, to determine if conventional treatments will be effective. If present, the biomarker causes greater chance of relapse. LSC17 causes makes cells dormant, allowing them to avoid effects of chemotherapy,